By Professor Leslie Burnett

Journal articles

Burcher S; Berman Y; Burnett L; Proos A; Clifton-Bligh R; Dwight T, 2014, 'Cardiac health professionals’ attitudes towards genetic testing for hereditary causes of cardiovascular disease', Heart, Lung and Circulation, 23, pp. e6 - e7, http://dx.doi.org/10.1016/j.hlc.2014.07.016

Neil A; Pfeffer S; Burnett L, 2013, 'Benchmarking in pathology: Development of a benchmarking complexity unit and associated key performance indicators', Pathology, 45, pp. 66 - 70, http://dx.doi.org/10.1097/PAT.0b013e32835b77c4

Lew RM; Proos AL; Burnett L; Delatycki M; Bankier A; Fietz MJ, 2012, 'Tay sachs disease in Australia: Reduced disease incidence despite stable carrier frequency in Australian jews', Medical Journal of Australia, 197, pp. 652 - 654, http://dx.doi.org/10.5694/mja12.11010

Burnett LB; Wilson RD; Pfeffer S; Lowry J; BIPAC , 2012, 'Benchmarking in pathology: Development of an activity-based costing model', Pathology, 44, pp. 644 - 653, http://dx.doi.org/10.1097/PAT.0b013e32835a9ec4

Lew R; Burnett L; Proos A, 2011, 'Tay-Sachs disease preconception screening in Australia: Self-knowledge of being an Ashkenazi Jew predicts carrier state better than does ancestral origin, although there is an increased risk for c.1421+1G>C mutation in individuals with South African heritage', Journal of Community Genetics, 2, pp. 201 - 209, http://dx.doi.org/10.1007/s12687-011-0057-x

Badrick T; Burnett L; Graham PE; Vervaart PP, 2010, 'Lost opportunities with Australia's health workforce?', Medical Journal of Australia, 193, pp. 484, http://dx.doi.org/10.5694/j.1326-5377.2010.tb04010.x

Burnett DL; Burnett L, 2010, 'A rare granulomatous reaction to Q fever vaccination following influenza vaccination.', The Medical Journal of Australia, 193, pp. 60 - 60

Burnett L, 2007, '2004 Pathway Tunisia Hotel Sidi Driss', Pathway, pp. 1 - 1

Burnett L; McQueen MJ; Jonsson JJ; Torricelli F; Ethics IFCCTO, 2007, 'IFCC position paper: report of the IFCC taskforce on ethics: introduction and framework.', Clinical Chemistry and Laboratory Medicine : CCLM / FESCC, 45, pp. 1098 - 1104

, 2007, 'Lonely Planet Tunisia 2007', , pp. 1 - 2

Barlow-Stewart K; Burnett L, 2006, 'Ethical considerations in the use of DNA for the diagnosis of diseases.', Clinical Biochemistry Reviews, 27, pp. 53 - 61

Warren E; Anderson R; Proos AL; Burnett L; Barlow-Stewart K; Hall J, 2005, 'Cost-effectiveness of a school-based Tay-Sachs and cystic fibrosis genetic carrier screening program.', Genetics in medicine : official journal of the American College of Medical Genetics, 7, pp. 484 - 494

Burnett L, 2004, 'Making national DNA databases safer. (vol 362, pg 1761, 2003)', LANCET, 363, pp. 902 - 902, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000220231500047&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

McKenzie S; Deane EM; Burnett L, 2004, 'Are serum cortisol levels a reliable indicator of wellbeing in the tammar wallaby, Macropus eugenii?', Comparative biochemistry and physiology. Part A, Molecular & integrative physiology, 138, pp. 341 - 348

Howell VM; Proos AL; LaRue D; Jensen CH; Beach F; Burnett L, 2004, 'Carrier screening for Canavan disease in Australia.', Journal of inherited metabolic disease, 27, pp. 289 - 290

Burnett L; Chesher D; Mudaliar Y, 2004, 'Improving the quality of information on pathology request forms.', Ann Clin Biochem, 41, pp. 53 - 56

Barlow-Stewart K; Burnett L; Proos AL; Howell VM; Huq F; Lazarus R; Aizenberg H, 2003, 'A genetic screening programme for Tay-Sachs disease and cystic fibrosis for Australian Jewish high school students.', Journal of medical genetics, 40, pp. e45 - e45

Burnett L, 2003, 'Making national DNA databases safer.', Lancet, 362, pp. 1761 - 1762

Burnett L; Barlow-Stewart K; Proos AL; Aizenberg H, 2003, 'The "GeneTrustee": a universal identification system that ensures privacy and confidentiality for human genetic databases.', Journal of law and medicine, 10, pp. 506 - 513

McKenzie S; Deane EM; Burnett L, 2002, 'Haematology and Serum Biochemistry of the Tammar Wallaby, Macropus eugenii', Comparative Clinical Pathology, 11, pp. 229 - 237

Groot-Obbink D; Hegedus G; Mackay MA; Proos AL; Burnett L; Chesher D; Rochester C; Shaw W; Webber A, 2002, 'ISO compliant laboratory quality systems and incident monitoring improve the implementation of laboratory information systems', Accred Qual Assur, 7, pp. 237 - 241

Burnett L; Chesher D; Burnett JR, 2002, 'Optimizing the availability of ’stat’ laboratory tests using Shewhart ’C’ control charts.', Ann Clin Biochem, 39, pp. 140 - 144

Bahar AY; Taylor PJ; Andrews L; Proos A; Burnett L; Tucker K; Friedlander M; Buckley MF, 2001, 'The frequency of founder mutations in the BRCA1, BRCA2, and APC genes in Australian Ashkenazi Jews: implications for the generality of U.S. population data.', Cancer, 92, pp. 440 - 445, http://dx.doi.org/10.1002/1097-0142(20010715)92:2<440::aid-cncr1340>3.0.co;2-o

Burnett L, 2001, 'EBM in the laboratory', The Medical Journal of Australia

Burnett L, 2000, 'Community genetics testing programs in Australia', Australian Journal of Medical Science, 21, pp. 50

Burnett L, 2000, 'Customer-focussed design of integrated laboratories', Australian Journal of Medical Science, 21, pp. 51

Burnett L, 2000, 'Genetics broker- the simple solution to the DNA debate', The Sydney Morning Herald, pp. 17 - 17

Watts B; Burnett L; Chesher D, 2000, 'Measurement of total protein is not a useful inclusion in liver function test profiles', Clinical Chemistry, 46, pp. 1022 - 1023

Goodrich ME; Goodrich ME; Cumming RG; Mitchell P; Koutts J; Burnett L, 1999, 'Plasma fibrinogen and other cardiovascular disease risk factors and cataract.', Ophthalmic Epidemiology, 6, pp. 279 - 290

Mitchell P; Smith W; Cumming RG; Leeder SR; Burnett L, 1998, 'Diabetes in an older Australian population', Diabetes Res Clin Pract, 41, pp. 177 - 184

Tsang CW; Tsang CW; Lazarus R; Smith W; Mitchell P; Koutts J; Burnett L, 1998, 'Hematological indices in an older population sample: derivation of healthy reference values', Clinical Chemistry, 44, pp. 96 - 101

Fleischer AC; Tait D; Mayo J; Burnett L; Simpson J, 1998, 'Sonographic features of ovarian remnants.', Journal of Ultrasound in Medicine, 17, pp. 551 - 555, http://dx.doi.org/10.7863/jum.1998.17.9.551

Burnett L, 1998, 'Taking charge', The Medical Journal of Australia

Chesher D; Burnett L, 1997, 'Equivalence of critical error calculations and process capability index C-pk', CLINICAL CHEMISTRY, 43, pp. 1100 - 1101, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1997XC89800046&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Chesher D; Burnett L, 1997, 'Equivalence of critical error calculations and process capability index Cpk.', Clinical Chemistry, 43, pp. 1100 - 1101, http://dx.doi.org/10.1093/clinchem/43.6.1100

Chesher D; Burnett L, 1997, '\textbfEquivalence of Critical Error \textbfCalculations and Process Capability \textbfIndex C pk ', Clinical Chemistry, 43, pp. 1100 - 1101

Burnett L; Rochester C; Mackay MA; Proos AL, 1997, 'Implementation of ISO 9001 in a medical testing laboratory', Accred Qual Assur, 2, pp. 76 - 81

Deane EM; Basden K; Burnett L; Proos AL; Cooper D, 1997, 'Serum analytes in the Tammar wallaby, Macropus eugenii', Aust Vet J, 75, pp. 141 - 142

Hall GH; Hamilton WT, 1996, 'Genetic testing.', Lancet, 347, pp. 685, https://www.ncbi.nlm.nih.gov/pubmed/8596392

Tan M-HH; Commens CA; Burnett L; Snitch PJ, 1996, 'A pilot study on the percutaneous absorption of microfine titanium dioxide from sunscreens.', The Australasian journal of dermatology, 37, pp. 185 - 187

Burnett L; Hegedus G; Chesher D; Burnett JR; Costaganna G, 1996, 'Application of process capability indices to quality control in a clinical chemistry laboratory', Clinical Chemistry, 42, pp. 2035 - 2037

Burnett L; Khoury M; Mackay MA, 1996, 'Error rates in Australian chemical pathology laboratories', The Medical Journal of Australia, 165, pp. 582 - 584

Khoury M; Burnett L; Mackay MA, 1996, 'Error rates in Australian chemical pathology laboratories.', The Medical Journal of Australia, 165, pp. 128 - 130

Howell VM; Burnett L, 1996, 'Genetic testing', Lancet, 347, pp. 685 - 686

Chesher D; Burnett L, 1996, 'Using Shewhart p control charts of external quality-assurance program data to monitor analytical performance of a clinical chemistry laboratory', Clinical Chemistry, 42, pp. 1478 - 1482

Burnett L; Chesher D, 1995, 'Application of CQI tools to the reduction in risk of needlestick injury.', Infection control and hospital epidemiology, 16, pp. 503 - 505

Giamboi E; Burnett L; Shaw W, 1995, 'Improving Laboratory Turnaround Time', CQI Annual, pp. 117 - 120

Siafakas N; Burnett L; Bennetts BH; Proos AL, 1995, 'Nonenzymatic extraction of DNA from blood collected into serum separator tubes.', Clinical Chemistry, 41, pp. 1045 - 1046

Brillante R; Brillante R; Yang V; Yang V; Proos AL; Burnett L, 1995, 'PCR analysis of hair root specimens to detect Tay-Sachs disease carriers in Ashkenazi Jews.', Clinical Chemistry, 41, pp. 321 - 322

Chesher D; Burnett L, 1995, 'Simple computer spreadsheet for standardized interpretation of oral glucose tolerance tests.', Pathology, 27, pp. 140 - 141

Back to profile page